(Q44265198)

1 December 2017

title

Interleukin 6 G-174 C polymorphism and breast cancer risk (English)

1 reference

1 December 2017

author

Cornelia M. van Duijn

8

object named as

C M van Duijn

1 reference

1 December 2017

6

A Hofman

1 reference

1 December 2017

Jacqueline C M Witteman

3

object named as

J Witteman

1 reference

1 December 2017

author name string

A M González-Zuloeta Ladd

1

1 reference

1 December 2017

A Arias Vásquez

2

1 reference

1 December 2017

A G Uitterlinden

4

1 reference

1 December 2017

J W Coebergh

5

1 reference

1 December 2017

B H Ch Stricker

7

1 reference

1 December 2017

publication date

23 May 2006

1 reference

European Journal of Epidemiology

1 December 2017

published in

1 reference

1 December 2017

volume

21

1 reference

1 December 2017

issue

5

1 reference

1 December 2017

page(s)

373-376

1 reference

https://scigraph.springernature.com/pub.10.1007/s10654-006-9005-1

1 December 2017

exact match

0 references

cites work

The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.

1 reference

12 December 2020

Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma

1 reference

12 December 2020

Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling

1 reference

12 December 2020

Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein

1 reference

12 December 2020

Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients

1 reference

12 December 2020

Determinants of disease and disability in the elderly: The Rotterdam elderly study

1 reference

12 December 2020

Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer

1 reference

12 December 2020

The -174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype

1 reference

12 December 2020

Interleukin-1 and interleukin-6 gene polymorphisms and the risk of breast cancer in caucasian women.

1 reference

12 December 2020

Quetelet index as indicator of obesity

1 reference

12 December 2020

The interleukin-6 gene: a susceptibility factor that may contribute to racial and ethnic disparities in breast cancer mortality

1 reference

12 December 2020

Expression of interleukin 6 (IL-6) correlates with oestrogen receptor in human breast carcinoma.

1 reference

12 December 2020

Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism

1 reference

12 December 2020

Cytokine gene polymorphisms and breast cancer susceptibility and prognosis

1 reference

12 December 2020

PALGA, of labor pains of the Pathological Anatomical District Automatized Archives

1 reference

12 December 2020

An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer

1 reference

12 December 2020

Normal breast epithelial cells produce interleukins 6 and 8 together with tumor-necrosis factor: defective IL6 expression in mammary carcinoma

1 reference

12 December 2020

Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma

1 reference

12 December 2020

-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer

1 reference

12 December 2020

GENEPOP (Version 1.2): Population Genetics Software for Exact Tests and Ecumenicism

1 reference

20 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/OXFORDJOURNALS.JHERED.A111573

Identifiers

DOI

10.1007/S10654-006-9005-1

1 reference

1 December 2017

1 reference